ArticleBMJ open2021

Impact of biological agents and tofacitinib for moderate-to-severe ulcerative colitis on health-related quality of life: a protocol for a network meta-analysis.

Xueni Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.